Why the study?
CKM syndrome is a complex condition impacting health through interrelated factors, but its relationship with pulse pressure in patients with type 2 diabetes mellitus required investigation.
Are cardiovascular-kidney-metabolic risk factors associated with pulse pressure in patients with type 2 diabetes?
Are cardiovascular-kidney-metabolic risk factors associated with pulse pressure in patients with type 2 diabetes?
In patients with type 2 diabetes, cardiovascular-kidney-metabolic risk factors such as age, BMI, albuminuria, and HbA1c are significantly correlated with increased pulse pressure, suggesting its utility as a marker for cardiorenal disease risk.
Answers are grounded in this paper and cite their sources.
Should not yet change CKM screening in T2DM; leaves open whether pulse pressure is an independent early marker.
CONTEXT: Cardiovascular–kidney–metabolic (CKM) syndrome is a complex condition arising from interrelated factors such as heart disease, diabetes mellitus (DM), kidney dysfunction, and obesity. These factors may cause multiple organ failure, thus impacting patient’s health. AIMS: The aim of this study was to explore the association between CKM risk factors, such as estimated glomerular filtration rate, blood pressure, albumin-creatinine ratio, age, body mass index (BMI), low-density lipoprotein cholesterol, glycated hemoglobin (HbA1c), and pulse pressure (PP) in patients with type 2 DM (T2DM). METHODOLOGY: Retrospective, cross-sectional study conducted using 32,333 T2DM patients’ data from Diamond database at a single center. Multivariate regression analysis assessed the relationship between PP and associated CKM risk factors. RESULTS: The analysis revealed significant positive correlations between PP and age ( r = 0.412), BMI ( r = 0.019), albuminuria ( r = 0.092), and HbA1c levels ( r = 0.115). The correlation between age and PP was found to be significant; a 1-year increase in age corresponded to a 0.474 mmHg rise in PP ( R 2 = 0.171; P < 0.001). CONCLUSIONS: PP, a crucial marker for cardiorenal disease in T2DM patients, can aid in determining the risk of developing CKM syndrome. Currently, strategies for identifying and managing CKM syndrome are not well defined, resulting in gaps in appropriate screening for metabolic risk factors, subclinical cardiovascular disease, and chronic kidney disease. However, assessment of these individual parameters and monitoring of PP can offer substantial benefits in the early detection and management of CKM syndrome, thereby improving patient outcomes.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: